Article Details
Retrieved on: 2021-10-24 14:23:54
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Roche's Genentech unit has won FDA approval for Susvimo, an implant for eyesight-robbing disease wet age-related macular degeneration (AMD) that ...
Article found on: pharmaphorum.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here